The PDF file includes: Table S1 . Cell lines and tumor samples used in this study. Table S2 . Antibodies and relevant ChIP conditions used in this study.
Other Supplementary Material for this manuscript includes the following:
(available at advances.sciencemag.org/cgi/content/full/4/10/eaau5935/DC1) Data file S1 (Microsoft Excel format). Related to PRC2 quantitation. Data file S2 (Microsoft Excel format). Histone modification quantitation. Peptides passing these quality control steps were used in final quantitation (representative SUZ12 peptide is shown as an example). (D) PRC2 quantitation in all cells. In the isogenic cell lines, sample size were; H3K27M mNEURON n=2, H3K27M 293 TREX n=1, H3K27M mESC n=3, H3WT mNEURON n=2, H3WT 293 TREX n=1, H3WT mESC n=4. In the glioma cell lines the sample sizes and specific cell lines used were as follows; H3K27M Glioma (DIPG XIII, DIPG N, DIPG IV) and H3WT Glioma n=3 (pcGBM2, GBML20, DIPG X). See Data S1 for additional details. Data Plotted as MeanSEM. Figure 4 . 293 TREX cells with doxycycline inducible H3.3K27M-or H3.3K27WT-bearing expression vectors and encoding 6xHIS-Tag on EZH2 and FLAG-tag on EED were probed for histones and PRC2 subunits. Expression of FLAG-tagged EED and HIS-tagged EZH2 was confirmed by western blot on cell lysates, as described. Induction was performed for 3 days with 1 µg/mL doxycycline showing the expression of the H3.3WT or H3.3K27M and a robust decrease in H3K27me3 in 293 TREX cells expressing H3.3K27M. (B) Mass-spectrometry confirmed the robust drop in H3K27me2-3 levels following 3 days of expressing H3.3K27M vs. H3K27WT. (C) Mass-spectrometry indicating that H3K27M histone peptide was not detectable after purification of PRC2 (see Fig. 4A ). Heatmaps for H3K27me3 and H3K36me2 were generated by centering and rank ordering the enrichment on those regions. Importantly, only 90 of the 132 sites are represented here to avoid overlap in lines. In doing so, we carefully selected specific cases that represent the most robust domains that lose H3K27me3 in the H3K27M case. While the loss of H3K27me3 occurred in both the 3' and 5' direction, we plotted all of those event in the same direction for illustrative purposes. Shown are the corresponding heatmaps for the 24 hr time point. Regions showing loss of H3K27me3 in the H3K27M cells exhibited a gain of H3K36me2. (C) Average density profiles corresponding to the heatmap selections indicate that regions which lose H3K27me3 (top), show a reciprocal retention of H3K36me2, which likely spreads from the adjacent H3K36me2 domain (bottom). (A) RNA-seq was performed on DIPG X (WT) and DIPG XIII (H3.3K27M) and differentially expressed genes were identified using DESeq2. An overall gain of H3K36me2 can be seen on genes that are upregulated (5,297 genes) in the H3.3K27M DIPG XIII cell line. An opposing relationship can be seen for downregulated genes (1,422 genes). (B) Ranked KEGG pathway analysis of the upregulated genes (cutoff for inclusion was bonferroni corrected p < .05).
